Hemispherx BioPharma (HEB)

[JohnnyD3]

You think they'd make it easy for us? :)

No timeline. When NIH announced this new initiative in late October - they said they would increase funding, do this study and Koroshetz, director of NINDS, said they would move fairly quickly - which it appears they are doing, in terms of huge bureaucracies that is. I imagine NIH will periodically post updates for program status. Nothing precludes them from naming the 'immunological agent' at any point along the process however. So your guess is as good as mine... but HEB employees and board members are accumulating shares - so if you don't have many shares, I'd do the same. Helluva price and the trend is up.